Concepedia

Coralie Cantarel

CC

Statistics

Publications

6

Citations

509

H-Index

6

Active since

2020

Affiliations

Inserm(Current)

Institut Bergonié

Université de Bordeaux

Centre d'Investigation Clinique Plurithématique de Bordeaux

Bordeaux Population Health

Coralie Cantarel is an author at Inserm specializing in oncology, radiation oncology, and medicine.

Top concepts

Publications per year

2020–2022

6

Publications

6

Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort

Antoîne Italiano, Alban Bessede, M. Pulido et al. · Nature Medicine · 2022 · 235 citations

, , +7

Regorafenib-Avelumab Combination in Patients with Microsatellite Stable Colorectal Cancer (REGOMUNE): A Single-arm, Open-label, Phase II Trial

Sophie Cousin, Coralie Cantarel, Jean‐Philippe Guégan et al. · Clinical Cancer Research · 2021 · 150 citations · Full text

Regorafenib–avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial

Sophie Cousin, Coralie Cantarel, Jean‐Philippe Guégan et al. · European Journal of Cancer · 2022 · 47 citations · Full text

, , +11

REGOMUNE: A phase II study of regorafenib plus avelumab in solid tumors—Results of the non-MSI-H metastatic colorectal cancer (mCRC) cohort.

Sophie Cousin, Carine Bellera, Jean‐Philippe Guégan et al. · Journal of Clinical Oncology · 2020 · 36 citations

, , +23

PD1 inhibition in soft-tissue sarcomas with tertiary lymphoid structures: A multicenter phase II trial.

Antoîne Italiano, Alban Bessede, Emmanuelle Bompas et al. · Journal of Clinical Oncology · 2021 · 21 citations

, , +18

1–5 of 6